Post by SOPHiA GENETICS

Our CEO, Ross Muken, joined CNBC International's Squawk Box yesterday to discuss how AI is transforming cancer care.   From analyzing massive genomic datasets to detecting cancer in the blood through liquid biopsy, new capabilities are helping move healthcare beyond a one-size-fits-all model and toward more personalized treatment.   Cancer is not a single disease, and no two patients are alike. By analyzing genomic and clinical data from prior patients, AI can help clinicians better understand each individual case and identify the right treatment for the right patient at the right time.   At SOPHiA GENETICS, we are putting this technology into real-world clinical use. Today, our AI platform is used by 1,000 healthcare institutions across more than 75 countries, with 2.5 million patient profiles analyzed to date.   Watch the full interview here: https://lnkd.in/g8Rs3BUQ

Video Content